Frontage Holdings Corporation (FGHQF)
FGHQF Stock Price Chart
Explore Frontage Holdings Corporation interactive price chart. Choose custom timeframes to analyze FGHQF price movements and trends.
FGHQF Company Profile
Discover essential business fundamentals and corporate details for Frontage Holdings Corporation (FGHQF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
14 Apr 2020
Employees
1.56K
Website
https://www.frontagelab.comCEO
Zhongping Lin
Description
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services that include study designs, execution of studies, and interpretation of the data through structural optimization in early discovery, pharmacokinetic studies in rodents, non- GLP bioanalytical studies, etc. The company also provides safety and toxicology services comprising in-vitro and in-vivo studies; bioequivalence services, which consist of designing, coordinating, and reporting of bioequivalence studies; chemistry services comprising contract research and custom synthesis services; and clinical services, such as early stage clinical, BE/BA, biometric, and data management services. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation is a subsidiary of Hongkong Tigermed Co., Limited.
FGHQF Financial Timeline
Browse a chronological timeline of Frontage Holdings Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Mar 2026
Earnings released on 28 Aug 2025
EPS came in at $0.00 , while revenue for the quarter reached $126.58M , beating expectations by +1.64%.
Earnings released on 27 Mar 2025
Revenue for the quarter reached $126.43M , missing expectations by -11.28%.
Earnings released on 28 Aug 2024
EPS came in at -$0.00 , while revenue for the quarter reached $128.48M .
Earnings released on 28 May 2024
EPS came in at $0.00 falling short of the estimated $0.01 by -69.90%, while revenue for the quarter reached $131.64M , missing expectations by -7.79%.
Earnings released on 29 Jun 2023
EPS came in at $0.00 , while revenue for the quarter reached $128.35M , missing expectations by -5.45%.
Earnings released on 28 Mar 2023
EPS came in at $0.01 falling short of the estimated $0.01 by -37.80%, while revenue for the quarter reached $131.82M , beating expectations by +0.53%.
Earnings released on 25 Aug 2022
EPS came in at $0.01 falling short of the estimated $0.01 by -38.70%, while revenue for the quarter reached $118.58M , missing expectations by -0.86%.
Earnings released on 28 Mar 2022
EPS came in at $0.00 falling short of the estimated $0.01 by -56.40%, while revenue for the quarter reached $91.92M , missing expectations by -11.37%.
Earnings released on 25 Aug 2021
EPS came in at $0.00 , while revenue for the quarter reached $91.92M , beating expectations by +14.89%.
Earnings released on 29 Mar 2021
EPS came in at $0.00 falling short of the estimated $0.01 by -58.70%, while revenue for the quarter reached $62.92M , missing expectations by -11.20%.
FGHQF Stock Performance
Access detailed FGHQF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.